133 related articles for article (PubMed ID: 23037152)
1. Tumor defense systems using O-glycans.
Tsuboi S
Biol Pharm Bull; 2012; 35(10):1633-6. PubMed ID: 23037152
[TBL] [Abstract][Full Text] [Related]
2. MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis.
Suzuki Y; Sutoh M; Hatakeyama S; Mori K; Yamamoto H; Koie T; Saitoh H; Yamaya K; Funyu T; Habuchi T; Arai Y; Fukuda M; Ohyama C; Tsuboi S
Int J Oncol; 2012 Jun; 40(6):1831-8. PubMed ID: 22446589
[TBL] [Abstract][Full Text] [Related]
3. Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.
Okamoto T; Yoneyama MS; Hatakeyama S; Mori K; Yamamoto H; Koie T; Saitoh H; Yamaya K; Funyu T; Fukuda M; Ohyama C; Tsuboi S
Mol Med Rep; 2013 Feb; 7(2):359-64. PubMed ID: 23165940
[TBL] [Abstract][Full Text] [Related]
4. A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans.
Tsuboi S; Sutoh M; Hatakeyama S; Hiraoka N; Habuchi T; Horikawa Y; Hashimoto Y; Yoneyama T; Mori K; Koie T; Nakamura T; Saitoh H; Yamaya K; Funyu T; Fukuda M; Ohyama C
EMBO J; 2011 Jun; 30(15):3173-85. PubMed ID: 21712812
[TBL] [Abstract][Full Text] [Related]
5. Two opposing roles of O-glycans in tumor metastasis.
Tsuboi S; Hatakeyama S; Ohyama C; Fukuda M
Trends Mol Med; 2012 Apr; 18(4):224-32. PubMed ID: 22425488
[TBL] [Abstract][Full Text] [Related]
6. Roles of O-linked oligosaccharides in immune responses.
Tsuboi S; Fukuda M
Bioessays; 2001 Jan; 23(1):46-53. PubMed ID: 11135308
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cells and solid tumors.
Stojanovic A; Cerwenka A
J Innate Immun; 2011; 3(4):355-64. PubMed ID: 21502747
[TBL] [Abstract][Full Text] [Related]
8. Expression of glycans linked to natural killer cell inhibition on the human zona pellucida.
Patankar MS; Ozgur K; Oehninger S; Dell A; Morris H; Seppala M; Clark GF
Mol Hum Reprod; 1997 Jun; 3(6):501-5. PubMed ID: 9239739
[TBL] [Abstract][Full Text] [Related]
9. Bench to bedside: NK cells and control of metastasis.
Krasnova Y; Putz EM; Smyth MJ; Souza-Fonseca-Guimaraes F
Clin Immunol; 2017 Apr; 177():50-59. PubMed ID: 26476139
[TBL] [Abstract][Full Text] [Related]
10. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
[TBL] [Abstract][Full Text] [Related]
11. Human natural killer cells: origin, receptors, function, and clinical applications.
Moretta L; Montaldo E; Vacca P; Del Zotto G; Moretta F; Merli P; Locatelli F; Mingari MC
Int Arch Allergy Immunol; 2014; 164(4):253-64. PubMed ID: 25323661
[TBL] [Abstract][Full Text] [Related]
12. [Natural killer (NK) cell and immunotherapy].
Iino T; Takaishi S
Nihon Rinsho; 2017 Feb; 75(2):306-311. PubMed ID: 30562869
[TBL] [Abstract][Full Text] [Related]
13. The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.
Wallace ME; Smyth MJ
Springer Semin Immunopathol; 2005 Jun; 27(1):49-64. PubMed ID: 15729567
[TBL] [Abstract][Full Text] [Related]
14. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
[TBL] [Abstract][Full Text] [Related]
15. [Non-specific killer cells in tumor immune response].
Kumagai K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):726-33. PubMed ID: 3985642
[TBL] [Abstract][Full Text] [Related]
16. [Natural cellular immunity as the effector mechanism in tumor defense].
Zielinski C; Müller C
Acta Med Austriaca; 1987; 14(2):34-6. PubMed ID: 3630578
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
Kopp HG; Placke T; Salih HR
Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cells. Role in resistance to cancer and infection.
Djeu JY
J Fla Med Assoc; 1991 Nov; 78(11):763-5. PubMed ID: 1765758
[TBL] [Abstract][Full Text] [Related]
19. Role of natural killer cells in the destruction of circulating tumor emboli.
Hanna N; Fidler IJ
J Natl Cancer Inst; 1980 Oct; 65(4):801-9. PubMed ID: 6932529
[TBL] [Abstract][Full Text] [Related]
20. Natural killer group 2D receptor and its ligands in cancer immune escape.
Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F
Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
